NasdaqGM - Nasdaq Real Time Price
USD
Harmony Biosciences Holdings, Inc. (HRMY)
38.76
+0.17
(+0.44%)
At close: October 30 at 4:00:01 PM EDT
38.63
-0.13
(-0.34%)
After hours: October 30 at 7:36:26 PM EDT
Trade HRMY on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreInsider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
|
Purchases
|
41,704 | 2 |
|
Sales
|
33,954 | 1 |
|
Net Shares Purchased (Sold)
|
7,750 | 3 |
|
Total Insider Shares Held
|
708.74k | -- |
|
% Net Shares Purchased (Sold)
|
1.10% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -10,710,399 |
| % Change in Institutional Shares Held | -18.37% |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| BUDUR KUMAR Officer |
Sale at price 41.98 - 43.10 per share. | Direct | 1,453,169 | Sep 8, 2026 |
| BUDUR KUMAR Officer |
Conversion of Exercise of derivative security at price 30.27 - 30.69 per share. | Direct | 699,942 | Sep 8, 2026 |
| BUDUR KUMAR Officer |
-- | Direct | -- | May 1, 2026 |
| ZAESKE ADAM H. Officer |
-- | Direct | -- | Apr 7, 2026 |
| KAPADIA SANDIP Chief Financial Officer |
Sale at price 37.15 per share. | Direct | 139,171 | Jan 26, 2026 |
| DAYNO JEFFREY M Chief Executive Officer |
-- | Direct | -- | Jan 23, 2026 |
| KAPADIA SANDIP Chief Financial Officer |
-- | Direct | -- | Jan 23, 2026 |
| SERAFIN ANDREW Officer |
-- | Direct | -- | Jan 23, 2026 |
| BUDUR KUMAR Officer |
-- | Direct | -- | Jan 23, 2026 |
| KAPADIA SANDIP Chief Financial Officer |
Sale at price 35.92 per share. | Direct | 752,833 | Jan 15, 2026 |
| DAYNO JEFFREY M Chief Executive Officer |
Sale at price 40.11 per share. | Direct | 1,040,103 | Dec 12, 2025 |
| DAYNO JEFFREY M Chief Executive Officer |
Conversion of Exercise of derivative security at price 8.22 per share. | Direct | 164,400 | Dec 12, 2025 |
| KAPADIA SANDIP Chief Financial Officer |
Sale at price 39.54 per share. | Direct | 790,896 | Dec 5, 2025 |
| KAPADIA SANDIP Chief Financial Officer |
Conversion of Exercise of derivative security at price 29.03 per share. | Direct | 580,600 | Dec 5, 2025 |
| KAPADIA SANDIP Chief Financial Officer |
Sale at price 35.00 per share. | Direct | 119,945 | Nov 21, 2025 |
| KAPADIA SANDIP Chief Financial Officer |
-- | Direct | -- | Sep 30, 2025 |
| KAPADIA SANDIP Chief Financial Officer |
Sale at price 36.50 per share. | Direct | 787,378 | Aug 15, 2025 |
| BUDUR KUMAR Officer |
-- | Direct | -- | May 1, 2025 |
| KAPADIA SANDIP Chief Financial Officer |
Sale at price 32.48 - 33.12 per share. | Direct | 227,386 | Apr 1, 2025 |
| KAPADIA SANDIP Chief Financial Officer |
-- | Direct | -- | Mar 28, 2025 |
| DIERKS JEFFREY G Officer |
Sale at price 32.61 - 33.23 per share. | Direct | 159,090 | Mar 3, 2025 |
| DIERKS JEFFREY G Officer |
Conversion of Exercise of derivative security at price 8.22 per share. | Direct | 40,023 | Mar 3, 2025 |
| KAPADIA SANDIP Chief Financial Officer |
Sale at price 38.05 per share. | Direct | 67,547 | Jan 27, 2025 |
| DIERKS JEFFREY G Officer |
Sale at price 36.94 - 38.02 per share. | Direct | 551,575 | Jan 27, 2025 |
| DAYNO JEFFREY M Chief Executive Officer |
-- | Direct | -- | Jan 24, 2025 |
| KAPADIA SANDIP Chief Financial Officer |
-- | Direct | -- | Jan 24, 2025 |
| DIERKS JEFFREY G Officer |
Conversion of Exercise of derivative security at price 30.69 per share. | Direct | 402,806 | Jan 24, 2025 |
| SERAFIN ANDREW Officer |
-- | Direct | -- | Jan 24, 2025 |
| BUDUR KUMAR Officer |
-- | Direct | -- | Jan 24, 2025 |
| DAYNO JEFFREY M Chief Executive Officer |
Sale at price 40.13 per share. | Direct | 774,245 | Jan 21, 2025 |
| DAYNO JEFFREY M Chief Executive Officer |
Conversion of Exercise of derivative security at price 8.22 per share. | Direct | 158,588 | Jan 21, 2025 |
| KAPADIA SANDIP Chief Financial Officer |
Sale at price 40.18 per share. | Direct | 1,004,598 | Jan 21, 2025 |
| KAPADIA SANDIP Chief Financial Officer |
Conversion of Exercise of derivative security at price 29.03 per share. | Direct | 725,750 | Jan 21, 2025 |
| DIERKS JEFFREY G Officer |
Sale at price 37.41 - 40.00 per share. | Direct | 1,147,715 | Jan 21, 2025 |
| DIERKS JEFFREY G Officer |
Conversion of Exercise of derivative security at price 33.44 per share. | Direct | 1,023,197 | Jan 21, 2025 |
| DIERKS JEFFREY G Officer |
Sale at price 37.01 per share. | Direct | 388,841 | Jan 15, 2025 |
| DIERKS JEFFREY G Officer |
Conversion of Exercise of derivative security at price 33.44 per share. | Direct | 351,354 | Jan 15, 2025 |
| DIERKS JEFFREY G Officer |
Sale at price 37.04 per share. | Direct | 265,946 | Jan 13, 2025 |
| DIERKS JEFFREY G Officer |
Conversion of Exercise of derivative security at price 33.44 per share. | Direct | 240,099 | Jan 13, 2025 |
| VALOR EQUITY PARTNERS Beneficial Owner of more than 10% of a Class of Security |
Sale at price 30.30 per share. | Direct | 139,391,500 | Nov 5, 2024 |
| MARSHMAN FUND TRUST II Beneficial Owner of more than 10% of a Class of Security |
Sale at price 30.30 per share. | Direct | 139,391,500 | Nov 5, 2024 |
| VALOR IV PHARMA HOLDINGS L.L.C. Beneficial Owner of more than 10% of a Class of Security |
Sale at price 30.30 per share. | Direct | 139,391,500 | Nov 5, 2024 |
